1. 当社のリクルーターシステムがどのように機能するかを真に理解していただくため、LinkedInでAIリクルーターを使用しているユーザーの実際の会話を選択しました。
2. これらの例は、AIリクルーターがさまざまなシナリオにどのように対応するかを示しています。
3. 個人情報を保護するため、すべてのデータは厳密に匿名化されています。

AIリクルーターの機能

すべての会話でAIリクルーターが行うこと

7×24即時返信
タイムゾーン制限なし、いつでも数秒で応答
多言語対応
言語を自動検出、50以上の言語をサポート
意図スクリーニング
候補者の興味と意欲をインテリジェントに評価
質問への回答
役職、給与、福利厚生の照会に自動で回答
自動フォローアップ
プロアクティブな複数回フォローアップ、手作業ゼロ
面接日程調整
時間枠を調整し、面接招待状を送信
連絡先情報の取得
会話中に自然に電話番号とメールアドレスを収集
Sha**ari

Sha**ari

会社:P**r役職:Head of Corporate Development勤務地:New York City Metropolitan Area,United States
会話記録
Hi S***y, I’m J***e, a recruiter at StrategyBrain. I was impressed by your two decades of leadership at P***r,especially your track record in M&A, licensing and corporate development. We’re partnering with B***s to find a Senior Vice President of Corporate Development and Strategic Partnerships. Would you be open to a brief chat to explore this opportunity?
Sha**ari
Hi J***e, thanks for reaching out and for the kind words! After 20 years leading M&A, licensing and corporate development at P***r, I’d love to hear more about the SVP role at B***s,when would be a good time to connect?
Hi S***y, great to hear from you,and thank you for your interest. B***s is a fast-growing biotech innovator in immunology, and the SVP, Corporate Development & Strategic Partnerships role sits on the executive leadership team. In this role you would: • Lead and execute global M&A, equity investments and divestiture strategies from target identification through post-merger integration. • Structure and negotiate high-value licensing, collaboration and joint-venture agreements with industry partners and financial sponsors. • Advise the CEO and Board on valuation, deal structuring and value-creation opportunities. • Build and mentor a world-class corporate development team to drive cross-functional alignment and execution. • Monitor market trends and competitive landscapes to uncover strategic growth and partnership opportunities. With your 20 years at P***r driving M&A, licensing and corporate development, you’d immediately shape our strategic roadmap and help accelerate breakthrough therapies to market. B***s offers a highly collaborative culture, global resources, and a competitive compensation package with equity upside. Does this capture what you’re looking for? I’d love to dive deeper,are you available for a 30-minute call tomorrow at 10:00 AM ET or Thursday at 2:00 PM ET? Let me know what works best, or feel free to suggest another time.
Sha**ari
Thanks, J***e,that sounds right up my alley. Before we chat, could you share a bit more on the equity upside and hybrid work model? I’m free Thursday at 2 PM ET if that works for you.
Hi S***y, Great questions. On the equity side, B***s offers a meaningful ownership stake at the SVP level: you’d receive an upfront grant of stock options (or RSUs) that vest over four years (with a one-year cliff), plus periodic, performance-based refreshers tied to key pipeline and business milestones. In combination with base salary and bonus, the package is designed to deliver significant upside as our immunology programs advance. Regarding hybrid work, we’ve adopted a flexible model,typically 2,3 days per week in our New York hub (or global office) for team collaboration and strategy sessions, with the balance fully remote. We also accommodate travel for investor meetings, conferences and key offsites. Thursday at 2:00 PM ET works perfectly. I’ll send a calendar invite shortly. Looking forward to diving deeper!
Sha**ari
Thanks J***e, that’s helpful. Quick follow-up: what kinds of pipeline or business milestones trigger the equity refreshers? And beyond investor meetings and offsites, any regular travel expectations? Looking forward to our chat Thursday at 2.
Hi S***y, Great questions. For equity refreshers, we tie them to both pipeline and business milestones,think key clinical inflection points (e.g., IND clearance, Phase II/III trial initiations or readouts), first patient dosing in pivotal studies, and commercial milestones such as initial drug approvals or launch ramp. On the business side, hitting strategic partnership or licensing deal close dates, hitting agreed revenue or co‐development funding thresholds, and successful divestitures can also trigger refresh grants. As for travel, beyond investor roadshows and our annual offsite, you’d expect roughly 20,30% travel,typically 1,2 days per month. That covers partner site visits (biotech collaborators, financial sponsors), due diligence trips for M&A targets, key industry conferences, and occasional global leadership summits. I’ll send over a Thursday 2:00 PM ET invite shortly. Looking forward to diving deeper then!
Sha**ari
Thanks, J***e,this is really helpful. One quick clarification: what’s the typical size of those refresh grants relative to the initial equity award? See you Thursday at 2 PM ET.
Hi S***y, Great question. While exact numbers vary based on performance and milestone achievement, at the SVP level our equity refreshers typically fall in the 25,35% range of your initial grant each year. In standout years,when you hit major clinical inflection points or close a strategic partnership,you can see refresh grants up toward 40,50% of that original award. We’ll of course tie the final numbers to our agreed milestones and your role’s scope. Looking forward to walking through the full comp framework on Thursday at 2 PM ET. Talk soon! Best, J***e
Sha**ari
Thanks, J***e,that refresh range aligns with what I’ve seen at P***r. Could you share when during the year those refresh grants typically vest and whether they’re front- or back-loaded? Looking forward to our chat on Thursday.
Hi S***y, Our refresh grants are typically approved at the start of our fiscal year (January) and vest over the following 12 months. For the standard refresh, we vest in equal quarterly installments (25% each quarter) to keep alignment throughout the year. Performance‐based refreshers tied to key milestones are slightly front-loaded,roughly 30% vests in the first half once early pipeline or deal milestones are hit, with the remaining 70% vesting in Q3/Q4 as full objectives are met. I’ll walk you through exact dates and sample schedules on our Thursday call. Looking forward to it! Best, J***e

AIリクルーターが候補者とコミュニケーションする方法

AIは実証済みの5ステップのワークフローに従います:スマートアウトリーチ → ニーズ発見 → インテリジェントQ&A → 情報収集 → 面接日程調整。

1 スマートアウトリーチ

AIは候補者のLinkedInプロファイルを分析 — 役職、スキル、業界、キャリアの軌跡 — その後、ポジションが彼らの背景と志向にどのように合致するかを強調する高度にパーソナライズされた最初のメッセージを生成します。AIは最適なタイミングでプロアクティブにアプローチし、各候補者のシニアティレベルに合わせてメッセージのトーンを調整します。

2 ニーズ発見

複数回の自然な対話を通じて、AIは候補者の本当のキャリアニーズを発見します — 希望する役職の種類、給与期待、勤務地の希望、成長の優先事項、変更を検討する理由を含みます。この洞察は、最も関連性の高い機会にマッチングするのに役立ちます。

3 インテリジェントQ&A

AIは役職に関する候補者の質問に自動的に回答します — 職務内容、給与レンジ、福利厚生、チーム構造、勤務形態(リモート/ハイブリッド/オフィス)、企業文化を含みます。回答は正確で文脈を考慮し、候補者の希望する言語で即座に提供されます。

4 情報収集

関心のある候補者について、AIは会話中に重要な情報を自然に収集します — 電話番号、メールアドレス、給与期待、最短開始可能日、稼働状況。すべてのデータは構造化され、リアルタイムでリクルーターダッシュボードと同期されます。

5 面接日程調整

AIは候補者と面接官の空き状況を調整し、適切な時間枠を提案し、ミーティング詳細(リンク、議題、面接官情報)を含む面接招待状を送信し、面接前に自動的にリマインダーを送信してドタキャンを最小限に抑えます。

AI Recruiterを体験する

無料で始めましょう。ライバルに先を越されないでください。

AI駆動の採用ソリューションを活用して、採用プロセスを自動化し、時間コストの80%を削減している10,000社以上の企業に加わりましょう。

33%オフ、残り48時間のみ!
AIを無料で試す

24時間365日自動運用

AIを活用した候補者スクリーニング

地理的・時差の制限なく採用活動

パーソナライズされたインテリジェントコミュニケーション

候補者エンゲージメントの自動評価

あなたの採用スタイルをインテリジェントに模倣・再現

4ヶ月間の返金保証

LinkedInアカウントのセキュリティを確保